In addition, gene interactions suggest a potential contribution of inducible and endothelial nitric oxide synthase (NOS2A and NOS3) gene polymorphisms to cardiovascular event susceptibility in patients with RA [16]. The gene discussed is NOS3; the disease is rheumatoid arthritis.